These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7807175)

  • 81. Effect of interferon-gamma on ACNU-induced DNA damage and cytotoxicity in human glioblastoma cells.
    Zhang W; Hara A; Murakawa T; Niikawa S; Andoh T; Sakai N; Yamada H
    Neurol Med Chir (Tokyo); 1993 May; 33(5):275-9. PubMed ID: 7687031
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
    Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
    Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains.
    Mineura K; Fushimi S; Kowada M; Isowa G; Ishizaki K; Ikenaga M
    Acta Neurochir (Wien); 1990; 103(1-2):62-6. PubMed ID: 2360469
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas.
    Nagane M; Asai A; Shibui S; Nomura K; Kuchino Y
    Neurosurgery; 1997 Aug; 41(2):434-40; discussion 440-1. PubMed ID: 9257312
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treatment of malignant glioma with high dose intra-arterial ACNU and autologous bone marrow transplantation--case report.
    Fujiwara T; Yoshioka J; Ohmoto T
    Neurol Med Chir (Tokyo); 1991 Oct; 31(10):654-7. PubMed ID: 1725815
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.
    Kawai H; Toyohara J; Kado H; Nakagawa T; Takamatsu S; Furukawa T; Yonekura Y; Kubota T; Fujibayashi Y
    Nucl Med Biol; 2006 Jan; 33(1):29-35. PubMed ID: 16459256
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Experimental studies on induced hypertension chemotherapy of intracerebral inoculated gliomas in rats].
    Tokuda K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):612-20. PubMed ID: 3463530
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation].
    Sampi K; Kumai R; Yanagawa S; Hattori M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2339-41. PubMed ID: 3044278
    [No Abstract]   [Full Text] [Related]  

  • 91. Enhancing effect of O6-alkylguanine derivatives on chloroethylnitrosourea cytotoxicity toward tumor cells.
    Mineura K; Izumi I; Watanabe K; Kowada M; Kohda K; Koyama K; Terashima I; Ikenaga M
    Int J Cancer; 1994 Sep; 58(5):706-12. PubMed ID: 8077057
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
    Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
    Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Concentration of ACNU in a branch of middle cerebral artery, femoral vein and brain tissue by intracarotid or intravenous administration in a patient with recurrent glioblastoma].
    Nakagawa H; Murasawa A; Nakajima S; Furuta Y; Nakajima Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2667-9. PubMed ID: 2774595
    [No Abstract]   [Full Text] [Related]  

  • 95. Significance of DNA cross-links on 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3- nitrosourea (ACNU)-induced cytotoxicity against ACNU-sensitive and -resistant lines of 9L rat glioma cells.
    Kokunai T; Tamaki N; Matsumoto S
    J Natl Cancer Inst; 1987 Jul; 79(1):119-22. PubMed ID: 3474438
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
    Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
    Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Therapeutic effects of photosensitizers in combination with laser and ACNU on an in vivo or in vitro model of cerebral glioma.
    Chen KT; Hau DM; You JS; Pan HC; Wong RW
    Chin Med J (Engl); 1995 Feb; 108(2):98-104. PubMed ID: 7774398
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Phase II trial of nimustine (ACNU; 3-[4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
    Joss RA; Siegenthaler P; Ludwig C; Alberto P; Castiglione MM; Cavalli F
    Invest New Drugs; 1986; 4(2):175-9. PubMed ID: 3015827
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
    Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
    J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
    Groves MD; Puduvalli VK; Chang SM; Conrad CA; Gilbert MR; Tremont-Lukats IW; Liu TJ; Peterson P; Schiff D; Cloughesy TF; Wen PY; Greenberg H; Abrey LE; DeAngelis LM; Hess KR; Lamborn KR; Prados MD; Yung WK
    J Neurooncol; 2007 Feb; 81(3):271-7. PubMed ID: 17031561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.